← Leaderboards
Raghava Potula
Temple Univ Of The Commonwealth
$4,276,324
Attributed
$7,005,559
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $730.9K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,005,559 · 4
By mechanism
R01$6,593,059 · 3
R21$412,500 · 1
Top collaborators
- Servio Heybert Ramirez6 shared
- Allison Michelle Andrews3 shared
- Wenzhe Ho3 shared
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Scott M Rawls$11,077,907
- Yuri Persidsky$27,976,914
- Servio Heybert Ramirez$5,873,481
- Allison Michelle Andrews$4,229,979
- Prasun K Datta$5,035,142
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsImmuneResponseFunctional DisorderEventAffectInsightInnovationComplexTissuesProteinsIn VivoAnimal ModelMethamphetamineIn VitroChronicNeuroinflammationNeuropathologyHiv InfectionsPharmaceutical PreparationsMouse ModelImmunityBlood - Brain Barrier AnatomyInfection
Grant awards (16)
Synthetic fentanyls adversely affect the blood-brain barrier and HIV replication in the context of neuroHIV$687,535
R01 · FY2025 · DA
Synthetic fentanyls adversely affect the blood-brain barrier and HIV replication in the context of neuroHIV$726,849
R01 · FY2024 · DA
Synthetic fentanyls adversely affect the blood-brain barrier and HIV replication in the context of neuroHIV$730,880
R01 · FY2023 · DA
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV$453,156
R01 · FY2022 · DA
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV$534,124
R01 · FY2021 · DA
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV$534,124
R01 · FY2020 · DA
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV$534,124
R01 · FY2019 · DA
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV$8,467
R01 · FY2019 · DA
Brain endothelial EVs role in the neuropathology of drugs of abuse and HIV$534,124
R01 · FY2018 · DA
Mechanism of immune dysregulation secondary to methamphetamine abuse.$371,025
R01 · FY2014 · DA · contact PI
Mechanism of immune dysregulation secondary to methamphetamine abuse.$356,184
R01 · FY2013 · DA · contact PI
Mechanism of immune dysregulation secondary to methamphetamine abuse.$371,025
R01 · FY2012 · DA · contact PI
Mechanism of immune dysregulation secondary to methamphetamine abuse.$371,025
R01 · FY2011 · DA · contact PI
Mechanism of immune dysregulation secondary to methamphetamine abuse.$380,417
R01 · FY2010 · DA · contact PI
METH-induced T cell Dysfunction: Role in HIV-1 Immunopathogenesis$187,500
R21 · FY2009 · DA · contact PI
METH-induced T cell Dysfunction: Role in HIV-1 Immunopathogenesis$225,000
R21 · FY2008 · DA · contact PI